SGXP Insider Trading Activity and SEC Form 4 Filings
SGXP insider trading summary
No open-market insider purchases or sales of Sgx Pharmaceuticals, Inc. (SGXP) have been reported on SEC Form 4 in the past 12 months.
Latest SGXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 15, 2008 | Siegfried Reich | VP, Drug Discovery | Sell | $2K (781 @ $2.98) |
| Aug 5, 2008 | W Todd Myers | CFO | Sell | $2K (781 @ $2.96) |
| Jul 15, 2008 | Siegfried Reich | VP, Drug Discovery | Sell | $306 (100 @ $3.06) |
| Jul 15, 2008 | Siegfried Reich | VP, Drug Discovery | Sell | $2K (681 @ $3.05) |
| Jul 7, 2008 | W Todd Myers | CFO | Sell | $1K (781 @ $1.60) |
| Jun 16, 2008 | Siegfried Reich | VP, Drug Discovery | Sell | $1K (781 @ $1.65) |
| Jun 5, 2008 | W Todd Myers | CFO | Sell | $1K (781 @ $1.35) |
| May 15, 2008 | Siegfried Reich | VP, Drug Discovery | Sell | $1K (781 @ $1.45) |
| May 5, 2008 | W Todd Myers | CFO | Sell | $1K (781 @ $1.43) |
| Apr 15, 2008 | Siegfried Reich | VP, Drug Discovery | Sell | $357 (300 @ $1.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.